NCT01806324

A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: HanAll BioPharma Co., Ltd. · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is: To evaluate the pharmacokinetics and safety of an experimental combination tablet containing 20 mg atorvastatin and 50 mg losartan potassium when administered orally as a single dose to healthy male subjects, compared with the concomitant administration of 20 mg atorvastatin and 50 mg losartan potassium tablets.

Conditions

• Hypertension
• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	HL040XC	single dose
DRUG	Losartan + Atorvastatin	Single dose

Timeline

• Start date: 2012-04-01
• Primary completion: 2012-11-01
• Completion: 2012-12-01
• First posted: 2013-03-07
• Last updated: 2013-03-07

Locations

1 site across 1 country: United States